Summary of the different mutations found in the MECP2 gene in male patients
Mutation | Pos | RS | De novo | Affected XY relatives | Affected XX relatives | Mother XCI | Comments | Ref |
---|---|---|---|---|---|---|---|---|
MBD, methyl binding domain; MR, relative presenting mental retardation; NA, not available; Pos, position with respect to known functional domains in the MECP2 protein; PPM-X, psychosis, pyramidal signs and macro-orchidism; RS, number of times this mutation was identified in a girl with Rett syndrome (according to the IRSA MECP2 variation database, http://mecp2.chw.edu.au/), RTT, relative affected by RS; SNE, severe neonatal encephalopathy; TRD, transcription repression domain; XCI, X-chromosome inactivation. | ||||||||
Non-pathogenic variants are not listed. | ||||||||
Missense mutations | ||||||||
R133C | MBD | 92 | No | None | RTT/MR | 85:15 | Mother has mild MR | Masuyama et al10 |
S134C | MBD | 12 | No | None | Atypical RTT | 98:2 | Budden et al11 | |
E137G | MBD | 0 | No | MR | None | Random | Unclassified variant | Couvert et al12 |
A140V | MBD | 0 | No | Severe MR | Mild MR | Random | Unclassified variant | Orrico et al13 |
MBD | 0 | No | Severe MR | None | Random | Unclassified variant | Couvert et al12 | |
MBD | 0 | No | PPM-X | Mild MR | Random | Unclassified variant | Klauck et al14 | |
F157I | MBD | 0 | Yes | Unclassified variant | Kankirawatana et al15 | |||
T158M | MBD | 191 | No | SNE | RTT | 99:1 | Villard et al16 | |
MBD | 191 | Yes | Lynch et al17 | |||||
R167W | 0 | No | Moderate MR | None | Random | Unclassified variant | Couvert et al12 | |
P225L | TRD | 0 | Yes | Unclassified variant | Moog et al18 | |||
P322S | 0 | No | None | MR | Random | Mother has mild MR | Ventura et al19 | |
Unclassified variant | ||||||||
R344W | 0 | NA | NA | NA | NA | Unclassified variant | Laccone et al20 | |
P405L | 0 | No | None | MR | NA | Mother has mild MR | Moog et al21 | |
Unclassified variant | ||||||||
K417M | 0 | No | None | None | Random | Unclassified variant | Kankirawatana et al15 | |
R453Q | 0 | NA | NA | NA | NA | Unclassified variant | Couvert et al12 | |
In-Frame deletions | ||||||||
P387del80 | 0 | No | Mild MR | None | 100:0 | Yntema et al22 | ||
Frameshifts and nonsense mutations | ||||||||
G163fs | 1 | No | RTT | NA | Geerdink et al23 | |||
G252fs | TRD | 3 | No | None | RTT | Germline mosaicism | Zeev et al24 | |
G269fs | TRD | 9 | No | None | RTT | Skewed | Mother has mild MR | Wan et al7 |
TRD | 9 | Yes | Leuzzi et al25 | |||||
TRD | 9 | Yes | Kankirawatana et al15 | |||||
R270fs | TRD | 3 | Yes | Kankirawatana et al15 | ||||
G273fs | TRD | 0 | Yes | Ravn et al26 | ||||
L386fs | 7 | No | None | None | 95:5 | Dayer et al27 | ||
Q406X | 0 | No | Severe MR | None | Random | Mild MR in a carrier female | Meloni et al28 | |
E472fs | 0 | Yes | Kleefstra et al29 | |||||
Large duplications | ||||||||
430 kb | 0 | No | None | None | 90:10 | Duplication of AVPR2 to FLNA | Meins et al30 | |
0.4–0.8 Mb | 0 | No | Severe MR | None | >85:15 | 4 duplications | Van Esch et al31 | |
0.4–0.8 Mb | 0 | No | Severe MR | None | >90:10 | 6 duplications | Friez et al32 | |
0.2–2.2 Mb | 0 | U | None | None | Skewed | 6 duplications and 1triplication | Del Gaudio et al33 | |
Abnormal karyotypes | ||||||||
Y141X/XXY | MBD | 6 | Yes | Schwartzman et al34 | ||||
T158M/XXY | MBD | 191 | Yes | 76% of XXY cells | Leonard et al35 | |||
E455X/XX | 1 | Yes | Heterozygous male | Maiwald et al36 | ||||
Somatic mosaicism | ||||||||
P56fs | 0 | Yes | Clayton-Smith et al37 | |||||
R133H | MBD | 3 | Yes | Armstrong et al38 | ||||
T158M | MBD | 191 | Yes | 25% mutant cells | Kleefstra et al39 | |||
R270X | TRD | 146 | Yes | 40% mutant cells | Topcu et al40 |